ClinConnect ClinConnect Logo
Search / Trial NCT07034157

A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis

Launched by BEIJING ANZHEN HOSPITAL · Jun 15, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Coronary Artery Disease Carotid Artery Stenosis Doppler Ultrasound Combined Vascular Intervention

ClinConnect Summary

This clinical study is looking at people who have heart artery disease and are about to have a procedure called percutaneous coronary intervention (PCI), which helps open blocked heart arteries. Researchers want to see how common it is for these patients to also have narrowing in the arteries of their head and neck, which can affect blood flow to the brain. They will use a simple, painless ultrasound test to check for this narrowing and will then study how different combined treatments work for these patients.

If you are 18 years or older and scheduled for this heart procedure, you might be able to join the study. Participants will have an ultrasound exam before their procedure, and the doctors will use the results to decide on the best treatment plan. The goal is to learn how to better care for people who have both heart and brain artery problems, improving their overall health and outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥18 years;
  • 2. Patients with coronary artery disease scheduled to undergo elective percutaneous coronary intervention (PCI) on the following day.
  • Exclusion Criteria:
  • 1. The expected survival is less than 1 years;
  • 2. Simultaneously merge other serious diseases;

About Beijing Anzhen Hospital

Beijing Anzhen Hospital is a leading medical institution in China, renowned for its expertise in cardiovascular diseases and comprehensive healthcare services. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation, facilitating the development of new therapies and treatment protocols. With a focus on patient safety and ethical standards, Beijing Anzhen Hospital collaborates with various research entities to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing the understanding of cardiovascular health. Its commitment to excellence in clinical research is underscored by a multidisciplinary team of experienced healthcare professionals and a state-of-the-art facility equipped to support a wide range of clinical investigations.

Locations

Beijing, , China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported